|
LM_ID
|
Common Name
|
Systematic Name
|
Species Shorthand
|
Formula
|
Mass
|
|
LMFA01030969
|
2-Hydroxy-22-methyltetracosanoic acid
|
2-hydroxy-22-methyltetracosanoic acid
|
FA 25:0;O
|
C25H50O3
|
398.375996
|
|
LMFA01030969
|
2-Hydroxy-22-methyltetracosanoic acid
|
2-hydroxy-22-methyltetracosanoic acid
|
FA 25:0;O
|
C25H50O3
|
398.375996
|
|
LMFA01030970
|
2-hydroxy-6-oxohexa-2,4-dienoic acid
|
2-hydroxy-6-oxohexa-2,4-dienoic acid
|
FA 6:3;O2
|
C6H6O4
|
142.026610
|
|
LMFA01030971
|
2-Methyl-2-pentenoic acid
|
(2Z)-2-methylpent-2-enoic acid
|
FA 6:1
|
C6H10O2
|
114.068080
|
|
LMFA01030972
|
2-Methyl-4-pentenoic acid
|
2-methylpent-4-enoic acid
|
FA 6:1
|
C6H10O2
|
114.068080
|
|
LMFA01030976
|
3-chloromuconic acid
|
3-chlorohexa-2,4-dienedioic acid
|
|
C6H5O4Cl
|
175.987638
|
|
LMFA01030978
|
3-hydroxybut-2-enoic acid
|
3-hydroxybut-2-enoic acid
|
FA 4:1;O
|
C4H6O3
|
102.031695
|
|
LMFA01030981
|
3-Methylsubericacid
|
3-methylsuberic acid
|
FA 9:1;O2
|
C9H16O4
|
188.104860
|
|
LMFA01030982
|
4-ene-Valproic acid
|
2-propylpent-4-enoic acid
|
FA 8:1
|
C8H14O2
|
142.099380
|
|
LMFA01030983
|
4-Ethyloctanoic acid
|
4-ethyloctanoic acid
|
FA 10:0
|
C10H20O2
|
172.146330
|
|
LMFA01030985
|
4-Methyl-2-pentenoic acid
|
(2Z)-4-methylpent-2-enoic acid
|
FA 6:1
|
C6H10O2
|
114.068080
|
|
LMFA01030989
|
5-formyl-2-hydroxyhepta-2,4-dienedioic acid
|
5-formyl-2-hydroxyhepta-2,4-dienedioic acid
|
FA 8:4;O4
|
C8H8O6
|
200.032090
|
|
LMFA01030994
|
8-Methylnonenoic acid
|
(6E)-8-methylnon-6-enoic acid
|
FA 10:1
|
C10H18O2
|
170.130680
|
|
LMFA01031001
|
C11354
|
(2E,4Z)-2-hydroxyhexa-2,4-dienoic acid
|
FA 6:2;O
|
C6H8O3
|
128.047345
|
|
LMFA01031015
|
mediomycin A
|
(2E,4E,6E,10E,13S,14S,15R,16E,18E,20E,22E,24E,26E,33R,35S,36E,39S,41R,43S,44E,47R,49S,50E,53R,55S)-58-amino-13,15,33,35,39,41,43,47,49,53,55-undecahydroxy-2,12,14,30-tetramethyl-31-oxo-29-(sulfooxy)octapentaconta-2,4,6,10,16,18,20,22,24,26,36,44,50-tridecaenoic acid
|
|
C62H97NO18S
|
1175.642641
|
|
LMFA01031015
|
mediomycin A
|
(2E,4E,6E,10E,13S,14S,15R,16E,18E,20E,22E,24E,26E,33R,35S,36E,39S,41R,43S,44E,47R,49S,50E,53R,55S)-58-amino-13,15,33,35,39,41,43,47,49,53,55-undecahydroxy-2,12,14,30-tetramethyl-31-oxo-29-(sulfooxy)octapentaconta-2,4,6,10,16,18,20,22,24,26,36,44,50-tridecaenoic acid
|
|
C62H97NO18S
|
1175.642641
|
|
LMFA01031015
|
mediomycin A
|
(2E,4E,6E,10E,13S,14S,15R,16E,18E,20E,22E,24E,26E,33R,35S,36E,39S,41R,43S,44E,47R,49S,50E,53R,55S)-58-amino-13,15,33,35,39,41,43,47,49,53,55-undecahydroxy-2,12,14,30-tetramethyl-31-oxo-29-(sulfooxy)octapentaconta-2,4,6,10,16,18,20,22,24,26,36,44,50-tridecaenoic acid
|
|
C62H97NO18S
|
1175.642641
|
|
LMFA01031015
|
mediomycin A
|
(2E,4E,6E,10E,13S,14S,15R,16E,18E,20E,22E,24E,26E,33R,35S,36E,39S,41R,43S,44E,47R,49S,50E,53R,55S)-58-amino-13,15,33,35,39,41,43,47,49,53,55-undecahydroxy-2,12,14,30-tetramethyl-31-oxo-29-(sulfooxy)octapentaconta-2,4,6,10,16,18,20,22,24,26,36,44,50-tridecaenoic acid
|
|
C62H97NO18S
|
1175.642641
|
|
LMFA01031016
|
mediomycin B
|
(2E,4E,6E,10E,13S,14S,15R,16E,18E,20E,22E,24E,26E,33R,35S,36E,39S,41R,43S,44E,47R,49S,50E,53R,55S)-58-amino-13,15,29,33,35,39,41,43,47,49,53,55-dodecahydroxy-2,12,14,30-tetramethyl-31-oxooctapentaconta-2,4,6,10,16,18,20,22,24,26,36,44,50-tridecaenoic acid
|
|
C62H97NO15
|
1095.685825
|
|
LMFA01031016
|
mediomycin B
|
(2E,4E,6E,10E,13S,14S,15R,16E,18E,20E,22E,24E,26E,33R,35S,36E,39S,41R,43S,44E,47R,49S,50E,53R,55S)-58-amino-13,15,29,33,35,39,41,43,47,49,53,55-dodecahydroxy-2,12,14,30-tetramethyl-31-oxooctapentaconta-2,4,6,10,16,18,20,22,24,26,36,44,50-tridecaenoic acid
|
|
C62H97NO15
|
1095.685825
|
|
LMFA01031016
|
mediomycin B
|
(2E,4E,6E,10E,13S,14S,15R,16E,18E,20E,22E,24E,26E,33R,35S,36E,39S,41R,43S,44E,47R,49S,50E,53R,55S)-58-amino-13,15,29,33,35,39,41,43,47,49,53,55-dodecahydroxy-2,12,14,30-tetramethyl-31-oxooctapentaconta-2,4,6,10,16,18,20,22,24,26,36,44,50-tridecaenoic acid
|
|
C62H97NO15
|
1095.685825
|
|
LMFA01031016
|
mediomycin B
|
(2E,4E,6E,10E,13S,14S,15R,16E,18E,20E,22E,24E,26E,33R,35S,36E,39S,41R,43S,44E,47R,49S,50E,53R,55S)-58-amino-13,15,29,33,35,39,41,43,47,49,53,55-dodecahydroxy-2,12,14,30-tetramethyl-31-oxooctapentaconta-2,4,6,10,16,18,20,22,24,26,36,44,50-tridecaenoic acid
|
|
C62H97NO15
|
1095.685825
|
|
LMFA08020162
|
(E,E)-2,4-Decadienoic isobutylamide
|
(2E,4Z)-N-(2-methylpropyl)deca-2,4-dienamide
|
NA 14:2
|
C14H25NO
|
223.193614
|
|
LMFA08020162
|
(E,E)-2,4-Decadienoic isobutylamide
|
(2E,4Z)-N-(2-methylpropyl)deca-2,4-dienamide
|
NA 14:2
|
C14H25NO
|
223.193614
|
|
LMFA08020163
|
1-(4-carboxybutanamido)-1'-(dimethylcarbamoyl)ferrocene
|
{(1,2,3,4,5-eta)-1-(4-carboxybutanamido)cyclopentadienyl}[(1,2,3,4,5-eta)-1-(dimethylcarbamoyl)cyclopentadienyl]iron
|
|
C18H22N2O4Fe
|
386.092898
|
|
LMFA08020164
|
2,4-Undecadiene-8,10-diynoic acid isobutylamide
|
(2E,4Z)-N-(2-methylpropyl)undeca-2,4-dien-8,10-diynamide
|
NA 15:6
|
C15H19NO
|
229.146664
|
|
LMFA08020164
|
2,4-Undecadiene-8,10-diynoic acid isobutylamide
|
(2E,4Z)-N-(2-methylpropyl)undeca-2,4-dien-8,10-diynamide
|
NA 15:6
|
C15H19NO
|
229.146664
|
|
LMFA08020165
|
Anacyclin
|
(2E,4E)-N-isobutyltetradeca-2,4-dien-8,10-diynamide
|
NA 18:6
|
C18H25NO
|
271.193614
|
|
LMFA08020165
|
Anacyclin
|
(2E,4E)-N-isobutyltetradeca-2,4-dien-8,10-diynamide
|
NA 18:6
|
C18H25NO
|
271.193614
|
|
LMFA08020166
|
asukamycin
|
(2E,4E,6E)-7-cyclohexyl-N-[(1S,5S,6R)-5-hydroxy-5-{(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trien-1-yl}-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]hepta-2,4,6-trienamide
|
|
C31H34N2O7
|
546.236603
|
|
LMFA08020166
|
asukamycin
|
(2E,4E,6E)-7-cyclohexyl-N-[(1S,5S,6R)-5-hydroxy-5-{(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trien-1-yl}-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]hepta-2,4,6-trienamide
|
|
C31H34N2O7
|
546.236603
|
|
LMFA08020166
|
asukamycin
|
(2E,4E,6E)-7-cyclohexyl-N-[(1S,5S,6R)-5-hydroxy-5-{(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trien-1-yl}-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]hepta-2,4,6-trienamide
|
|
C31H34N2O7
|
546.236603
|
|
LMFA08020166
|
asukamycin
|
(2E,4E,6E)-7-cyclohexyl-N-[(1S,5S,6R)-5-hydroxy-5-{(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trien-1-yl}-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]hepta-2,4,6-trienamide
|
|
C31H34N2O7
|
546.236603
|
|
LMFA08020167
|
beta-sanshool
|
(2E,6E,8E,10E)-N-(2-methylpropyl)dodeca-2,6,8,10-tetraenamide
|
NA 16:4
|
C16H25NO
|
247.193614
|
|
LMFA08020167
|
beta-sanshool
|
(2E,6E,8E,10E)-N-(2-methylpropyl)dodeca-2,6,8,10-tetraenamide
|
NA 16:4
|
C16H25NO
|
247.193614
|
|
LMFA08020168
|
BRN 2646116
|
(2E,4E)-N-isobutyl-6-phenyl-hexa-2,4-dienamide
|
NA 16:6
|
C16H21NO
|
243.162314
|
|
LMFA08020168
|
BRN 2646116
|
(2E,4E)-N-isobutyl-6-phenyl-hexa-2,4-dienamide
|
NA 16:6
|
C16H21NO
|
243.162314
|
|
LMFA08020168
|
BRN 2646116
|
(2E,4E)-N-isobutyl-6-phenyl-hexa-2,4-dienamide
|
NA 16:6
|
C16H21NO
|
243.162314
|
|
LMFA08020169
|
Deferoxamine
|
N-(5-aminopentyl)-N-hydroxy-N'-[5-(N-hydroxy-3-{[5-(N-hydroxyacetamido)pentyl]carbamoyl}propanamido)pentyl]butanediamide
|
|
C25H48N6O8
|
560.353363
|
|
LMFA08020171
|
desferrioxamine G
|
32-amino-5,16,27-trihydroxy-4,12,15,23,26-pentaoxo-5,11,16,22,27-pentaazadotriacontan-1-oic acid
|
|
C27H50N6O10
|
618.358843
|
|
LMFA08020172
|
EI-1511-3
|
(2E,4E)-N-[(1S,5S,6R)-5-hydroxy-5-{(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trien-1-yl}-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-7-methylocta-2,4-dienamide
|
|
C27H30N2O7
|
494.205303
|
|
LMFA08020172
|
EI-1511-3
|
(2E,4E)-N-[(1S,5S,6R)-5-hydroxy-5-{(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trien-1-yl}-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-7-methylocta-2,4-dienamide
|
|
C27H30N2O7
|
494.205303
|
|
LMFA08020172
|
EI-1511-3
|
(2E,4E)-N-[(1S,5S,6R)-5-hydroxy-5-{(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trien-1-yl}-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-7-methylocta-2,4-dienamide
|
|
C27H30N2O7
|
494.205303
|
|
LMFA08020172
|
EI-1511-3
|
(2E,4E)-N-[(1S,5S,6R)-5-hydroxy-5-{(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trien-1-yl}-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-7-methylocta-2,4-dienamide
|
|
C27H30N2O7
|
494.205303
|
|
LMFA08020172
|
EI-1511-3
|
(2E,4E)-N-[(1S,5S,6R)-5-hydroxy-5-{(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trien-1-yl}-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-7-methylocta-2,4-dienamide
|
|
C27H30N2O7
|
494.205303
|
|
LMFA08020173
|
EI-1511-5
|
(2E,4E,6E)-N-[(1S,5S,6R)-5-hydroxy-5-{(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trien-1-yl}-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-8-methyldeca-2,4,6-trienamide
|
|
C29H32N2O7
|
520.220953
|
|
LMFA08020173
|
EI-1511-5
|
(2E,4E,6E)-N-[(1S,5S,6R)-5-hydroxy-5-{(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trien-1-yl}-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-8-methyldeca-2,4,6-trienamide
|
|
C29H32N2O7
|
520.220953
|
|
LMFA08020173
|
EI-1511-5
|
(2E,4E,6E)-N-[(1S,5S,6R)-5-hydroxy-5-{(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trien-1-yl}-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-8-methyldeca-2,4,6-trienamide
|
|
C29H32N2O7
|
520.220953
|
|
LMFA08020173
|
EI-1511-5
|
(2E,4E,6E)-N-[(1S,5S,6R)-5-hydroxy-5-{(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trien-1-yl}-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-8-methyldeca-2,4,6-trienamide
|
|
C29H32N2O7
|
520.220953
|
|
LMFA08020173
|
EI-1511-5
|
(2E,4E,6E)-N-[(1S,5S,6R)-5-hydroxy-5-{(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trien-1-yl}-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-8-methyldeca-2,4,6-trienamide
|
|
C29H32N2O7
|
520.220953
|